Larvol Delta - NEBULA-Study-of-NG641-in-Combination-With-Nivolumab-in-Metastatic-or-Advanced-Epithelial-Tumours

NG-641 - Akamis Bio

Opdivo (nivolumab) - BMS

http://clinicaltrials.gov/ct2/show/NCT05043714

Mar 24, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next